瑞士罗氏公司与美国太马公司(Trimeris)合作研制了一种新型的艾滋病药物Fuzeon。这是一种HIV病毒融合抑制剂.主要用十已经耐受其他艾滋病药物的患者。不同于目前的抗HIV药物作用于感染后的免疫细胞,该药主要阻止HIV病毒进入健康的免疫细胞内。 该药的生产基地在美国科罗拉多州Boulder市,由于药物结构复杂,生 Roche, Switzerland and the United States Trimes (Trimeris) to develop a new type of AIDS drug Fuzeon. This is a HIV virus fusion inhibitor, mainly used in ten patients who have been resistant to other AIDS drugs. Unlike current anti-HIV drugs that act on infected immune cells, the drug largely blocks the HIV virus from entering healthy immune cells. The drug production base in Boulder, Colorado, the United States, due to the complex drug structure, Health